Last10K.com

Core Laboratories N V (CLB) SEC Filing 10-Q Quarterly report for the period ending Sunday, September 30, 2018

Core Laboratories N V

CIK: 1000229 Ticker: CLB


corelablogo.gif    

FOR IMMEDIATE RELEASE

CORE LAB REPORTS THIRD QUARTER 2018 RESULTS FROM CONTINUING OPERATIONS:

REVENUE OF $182.1 MILLION, UP 12% YEAR-OVER-YEAR
OPERATING MARGINS OF 19%; EX-ITEMS 20%, UP OVER 360 BPS YEAR-OVER-YEAR
EPS OF $0.50; $0.64 EX-ITEMS, UP 39% YEAR-OVER-YEAR
COMPANY POSTS OILFIELD SERVICE-LEADING ROIC OF 28%
COMPANY TOTAL SHAREHOLDER RETURNS OUTPACING OSX YEAR-TO-DATE

AMSTERDAM (24 October 2018) - Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported that continuing operations resulted in third quarter 2018 revenue of $182,100,000, up 12% year-over-year, with operating income of $34,900,000, up 31% year-over-year, and earnings per diluted share ("EPS") of $0.50, all in accordance with U.S. generally accepted accounting principles ("GAAP"); EPS, ex-items, a non-GAAP financial measure, increased 39% year-over-year to $0.64. Reconciliations of non-GAAP financial measures are included in the attached financial tables.

Operating margins for the Company increased over 360 basis points to 20% with incremental margins of 51%, ex-items, year-over-year. The expanding year-over-year operating margins are the result of higher technology services and products being requested by Core’s technologically sophisticated client base and increased utilization of the Company’s services and products, particularly in the U.S market.

Core’s Board of Supervisory Directors ("Board") and the Company’s Executive Management continue to focus on strategies that maximize return on invested capital ("ROIC") and free cash flow ("FCF"), a non-GAAP financial measure defined as cash from operations less capital expenditures, while exercising capital discipline, factors which have high correlation with maximizing total shareholder return. Core’s asset-lite business model promotes asset efficiency, designed to produce more predictable, superior long-term, and sustainable ROIC. Bloomberg’s calculations using the latest comparable data available indicate that Core’s ROIC of 28% is the highest for all major companies in its oilfield service Comp Group.

Segment Highlights

Reservoir Description

Reservoir Description is heavily exposed to international and offshore activity levels. Over 80% of its revenue is sourced outside the U.S., where core, reservoir fluid and derived product samples originate from international projects. Delays in the recovery of international and deepwater field development activity impacted and delayed revenue opportunities for the Company’s Reservoir Description segment during the third quarter of 2018. Revenue in the third quarter of 2018 was $103,600,000 with operating income on a



The following information was filed by Core Laboratories N V (CLB) on Wednesday, October 24, 2018 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Core Laboratories N V's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Core Laboratories N V.

Continue

Assess how Core Laboratories N V's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Core Laboratories N V's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
Legal
Other
Filter Subcategory:
All
Earnings
Expense
Cash Flow
Product
Income
Other
Inside Core Laboratories N V's 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Consolidated Balance Sheets Balance Sheet Parenthetical
Consolidated Balance Sheets Statement
Consolidated Statement Of Other Comprehensive Income
Consolidated Statements Of Cash Flows Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations Statement
Acquisitions (Details)
Acquisitions Acquisitions
Basis Of Presentation
Basis Of Presentation (Details)
Commitments And Contingencies
Contract Assets And Contract Liabilities
Contract Assets And Contract Liabilities (Tables)
Contract Assets And Contract Liabilities - Changes In Net Contract Assets (Liabilities) (Details)
Contract Assets And Contract Liabilities - Current And Long-Term Contract Liabilities (Details)
Derivative Instruments And Hedging Activities
Derivative Instruments And Hedging Activities (Details)
Derivative Instruments And Hedging Activities (Tables)
Derivative Instruments And Hedging Activities - Effect Of Interest Rate Swaps On Statement Of Operations (Details)
Discontinued Operations
Discontinued Operations (Details)
Discontinued Operations (Tables)
Earnings Per Share
Earnings Per Share (Details)
Earnings Per Share (Tables)
Equity
Equity (Comprehensive Income) (Details)
Equity (Details)
Equity (Narrative) (Details)
Equity (Tables)
Financial Instruments
Financial Instruments (Details)
Financial Instruments (Tables)
Income Tax Expense
Income Tax Expense (Details)
Inventories
Inventories (Details)
Inventories (Tables)
Long-Term Debt
Long-Term Debt (Details)
Long-Term Debt (Tables)
Other (Income) Expense, Net
Other (Income) Expense, Net (Details)
Other (Income) Expense, Net (Foreign Currency (Gain) Loss By Currency) (Details)
Other (Income) Expense, Net (Tables)
Pensions
Pensions (Details)
Pensions (Tables)
Recent Accounting Pronouncements
Segment Reporting
Segment Reporting (Details)
Segment Reporting (Tables)
Significant Accounting Policies Update
Significant Accounting Policies Update (Details)
Significant Accounting Policies Update (Policies)

Material Contracts, Statements, Certifications & more

Core Laboratories N V provided additional information to their SEC Filing as exhibits

Ticker: CLB
CIK: 1000229
Form Type: 10-Q Quarterly Report
Accession Number: 0001000229-18-000119
Submitted to the SEC: Thu Oct 25 2018 1:06:01 PM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Sunday, September 30, 2018
Industry: Oil And Gas Field Services

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/clb/0001000229-18-000119.htm